multipl
sclerosi
ms
inflammatori
demyelin
neurolog
diseas
autoreact
lymphocyt
sensit
myelin
compon
central
nervou
system
postul
contribut
pathogenesi
possibl
relev
molecular
mimicri
human
coronaviru
myelin
basic
protein
compon
myelin
gener
autoimmun
reaction
evalu
myelin
basic
proteinand
virusreact
tcell
line
establish
ms
patient
healthi
donor
shown
mostli
contrast
healthi
donor
sever
tcell
line
isol
ms
patient
show
crossreact
myelin
coronaviru
antigen
overal
tcell
line
ms
patient
donor
tcell
line
normal
control
subject
donor
show
hladrrestrict
crossreact
pattern
antigen
activ
vitro
select
either
myelin
basic
protein
human
coronaviru
strain
antigen
moreov
reciproc
reactiv
observ
ms
patient
donor
establish
molecular
mimicri
common
viral
pathogen
human
coronaviru
myelin
possibl
immunopatholog
mechan
ms
consist
possibl
involv
one
infecti
pathogen
environment
trigger
diseas
talbot
pj
paquett
js
ciurli
c
antel
jp
oueller
f
myelin
basic
protein
n
h
u
n
coronaviru
crossreact
cell
multipl
sclerosi
copyright
lope
positivestrand
rna
virus
respiratori
pathogen
involv
common
cold
known
human
isol
group
two
serotyp
design
support
possibl
involv
neurolog
diseas
ms
deriv
sever
line
studi
relat
murin
coronavirus
caus
mslike
immun
systemdepend
chronic
andor
recurr
cn
demyelin
diseas
rodent
primat
coronaviruslik
particl
observ
brain
ms
patient
murinelik
coronavirus
isol
ms
patient
lo
titer
antibodi
serotyp
human
coronavirus
elev
cerebrospin
fluid
ms
patient
compar
control
subject
human
coronavirus
capac
replic
cultur
neural
glial
cell
human
origin
two
group
includ
recent
report
coronaviru
gene
express
brain
significantli
higher
proport
ms
patient
control
subject
activ
myelinreact
cell
found
increas
frequenc
peripher
circul
multipl
sclerosi
ms
chronic
diseas
central
nervou
system
cn
character
multifoc
region
inflamm
myelin
destruct
clinic
diseas
onset
common
young
adult
diseas
preval
unevenli
distribut
geograph
avail
evid
suggest
etiolog
ms
multifactori
probabl
involv
combin
genet
suscept
environment
trigger
factor
genet
predisposit
may
involv
immun
respons
gene
encod
major
histocompat
complex
tcell
receptor
tcr
complex
gene
region
howev
low
concord
rate
among
monozygot
twin
epidemiolog
studi
also
implic
environment
factor
microbi
infect
commonli
cite
trigger
event
associ
ms
repeat
attempt
made
identifi
mslink
pathogen
dozen
differ
virus
associ
ms
year
without
clear
causal
relationship
yet
establish
coronavirus
appear
long
list
candid
implic
diseas
etiolog
envetrathec
compart
ms
patient
compar
control
subject
mechan
underli
activ
myelinreact
cell
remain
obscur
interestingli
coronaviru
infect
experiment
anim
lead
activ
similar
autoreact
cell
transfer
naiv
anim
trigger
experiment
allerg
encephalomyel
eae
autoimmun
diseas
also
use
model
ms
usual
induc
inject
myelin
basic
protein
mbp
proteolipid
protein
plp
adjuv
although
mechan
involv
virusinduc
autoimmun
known
molecular
mimicri
suggest
underli
trigger
event
inde
molecular
mimicri
often
propos
involv
pathogenesi
ms
although
experiment
evid
thu
far
lack
presum
share
amino
acid
sequenc
viru
selfantigen
mbp
could
result
activ
infecti
agent
lymphocyt
recogn
share
sequenc
cell
may
abl
recogn
selfantigen
immunopatholog
consequ
without
accompani
persist
viral
infect
share
sequenc
variou
virus
mbp
plp
report
sever
year
ago
although
biolog
consequ
identifi
w
e
also
recent
found
structur
mimicri
nonstructur
protein
strain
human
coronaviru
region
mbp
close
immunodomin
site
observ
ms
patient
known
encephalitogen
experiment
anim
w
e
hypothes
molecular
mimicri
group
common
respiratori
pathogen
myelin
constitu
could
underli
initi
persist
andor
recurr
cnsdirect
autoreact
immun
respons
associ
ms
accord
hypothesi
ms
would
trigger
individu
genet
predispos
mount
immun
respons
sequenc
infect
pathogen
human
coronaviru
share
myelin
antigen
thu
reason
ms
patient
would
preferenti
express
virusmyelin
crossreact
cell
sixteen
patient
diagnos
ms
select
random
patient
show
chronic
progress
relapsingremit
diseas
fourteen
healthi
donor
select
random
control
subject
donor
year
old
mean
age
year
histocornpat
profil
establish
serolog
human
leukocyt
antigen
hla
class
antigen
hladr
assign
confirm
molecular
assay
tabl
human
mbp
prepar
normal
male
adult
human
brain
montreal
brain
bank
dougla
hospit
verdun
qukbec
canada
accord
procedur
cheifetz
moscarello
puriti
monitor
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
expect
singl
band
kd
observ
coomassi
blue
stain
lyophil
stock
store
reconstitut
concentr
mgml
complet
rpmi
cultur
medium
describ
score
obtain
american
type
cultur
collect
atcc
rockvil
md
propag
human
embryon
lung
cell
line
human
coronaviru
also
obtain
atcc
propag
human
rectal
tumor
cell
line
viral
antigen
prepar
cell
infect
moi
hour
cell
infect
moi
hour
control
antigen
prepar
parallel
cultur
uninfect
cell
respect
cell
lyse
cultur
medium
three
cycl
freez
thaw
c
clarifi
g
minut
yield
viral
control
antigen
store
aliquot
use
infecti
viru
viral
antigen
prepar
tissu
cultur
infecti
dose
ml
inactiv
exposur
ultraviolet
light
ulrraviolet
illumin
model
fotodyn
new
berlin
wi
minut
tcell
line
prepar
accord
modif
method
pett
colleagu
b
briefli
peripher
blood
lymphocyt
separ
ficolllhypaqu
pharmacia
densiti
gradient
centrifug
resuspend
x
cellsml
complet
cultur
medium
gibco
wmi
contain
mm
l
glutamin
unitslml
penicillin
pgml
streptomycin
mm
hepe
pm
volvol
heatinactiv
pool
ab
serum
pelfreez
brown
deer
wi
volvol
heatinactiv
minut
autolog
serum
cell
seed
x
loi
cell
per
well
ml
roundbottom
microtit
plate
icnflow
either
mbp
viral
antigen
ad
final
concentr
pgml
pgiwel
mbp
final
dilut
viral
antigen
day
incub
humidifi
atmospher
contain
volvol
carbon
dioxid
ml
cultur
medium
per
well
supplement
unit
human
recombin
immunex
seattl
wa
per
millilit
ad
repeat
everi
day
total
day
primari
tcell
line
screen
antigendepend
prolifer
tcell
line
microtit
plate
wash
twice
serumfre
complet
cultur
niediuin
remov
free
centrifug
ooog
minut
resuspend
ml
complet
cultur
medium
per
well
split
two
new
roundbottom
microtit
plate
plwell
autolog
peripher
blood
lymphocyt
prepar
describ
irradi
rad
ad
x
cell
antigenpres
cell
microtit
plate
one
two
plate
also
receiv
specif
antigen
either
mbp
viral
antigen
quantiti
describ
plwell
plate
receiv
serumfre
complet
cultur
medium
cell
lysat
cultur
medium
pllwell
cell
fed
human
recombin
everi
day
total
day
describ
antigenspecif
tcell
line
select
expans
prolifer
assay
cell
wash
twice
remov
free
restimul
concentr
x
cellsml
complet
cultur
medium
irradi
antigenpres
cell
ratio
antigen
ad
prolifer
assay
describ
perform
aliquot
cell
human
recombin
ad
remain
cell
everi
day
total
day
describ
antigen
restimul
protocol
repeat
one
three
time
total
three
five
vitro
stimul
prolifer
assay
perform
ad
x
lo
cell
per
well
roundbottom
microtit
plate
irradi
antigenpres
cell
variou
antigen
ad
separ
complet
cultur
medium
duplic
triplic
well
antigen
mlwell
specif
control
antigen
mbp
pgiwel
pg
mbpreactiv
line
pg
virusreact
line
experiment
establish
optim
viral
antigen
infect
cell
lysat
final
dilut
optim
dilut
virusreact
line
tetanu
toxoid
pg
previous
test
optim
appropri
dilut
uninfect
cell
lysat
serumfre
complet
cultur
medium
incorpor
presenc
specif
antigen
control
valu
least
cpm
incorpor
consid
signific
doserespons
curv
perform
antigen
observ
prolifer
found
gradual
increas
specif
amount
antigen
describ
optim
either
remain
stabl
decreas
antigen
use
mbp
viral
anrigen
use
prolifer
assay
prepar
describ
peripher
blood
lymphocyt
donor
describ
tabl
interest
relationship
sever
neurolog
dysfunct
ms
diagnosi
crossreact
pattern
involv
mani
patient
expand
disabl
statu
scale
edss
score
lower
patient
edss
score
equal
higher
data
shown
observ
patient
relapsingremit
chronic
progress
diseas
see
tabl
although
appar
correl
hla
type
reactiv
pattern
interest
note
presum
patholog
mbp
lost
reactiv
mbp
even
though
react
viru
data
shown
reactiv
antigen
independ
sinc
observ
antigenpres
cell
control
antigen
tetanu
toxoid
loss
reactiv
antigen
observ
tcell
line
select
presenc
viru
two
pi
ms
patient
unusu
tcell
reactiv
profil
observ
yield
tcell
line
crossreact
pattern
involv
mbp
viru
ms
patient
loss
reactiv
mbp
use
vitro
select
antigen
previous
observ
accompani
acquisit
reactiv
measl
viru
remain
possibl
cell
inde
virusmbp
crossreact
becom
nonrespons
mbp
posibl
suppressor
epitop
found
molecul
viru
inde
tcell
line
clone
recent
report
gener
higher
frequenc
prolifer
better
synthet
peptid
homolog
immunodomin
epitop
mbp
rather
whole
molecul
preliminari
verif
clonal
use
semiquantit
revers
transcriptasepolymeras
chain
reaction
procedur
identifi
vp
molecul
tcr
mbpreactiv
tcell
line
obtain
ms
patient
tcell
line
recogn
mbp
exclus
express
chain
tcell
line
react
mbp
express
molecul
data
shown
prolif
respons
mbp
viral
antigen
block
monoclon
antibodi
hla
class
ii
antigen
exampl
stimul
indic
mbp
viru
mbpreactiv
line
reduc
respect
isotyp
control
antibodi
effect
observ
hlamismatch
antigenpres
cell
consist
hlarestrict
respons
data
shown
hladr
identifi
restrict
element
previou
studi
also
show
mbpreactiv
cell
final
interest
evalu
viru
specif
tcell
line
react
mbp
antigen
purpos
mbpor
crossreact
tcell
line
obtain
patient
pilplg
see
tabl
also
test
reactiv
antigen
observ
crossreact
human
coronaviru
serotyp
despit
fact
donor
seroposit
viru
tcell
line
could
gener
ms
patient
tri
pi
observ
strengthen
possibl
observ
crossreact
pattern
result
molecular
mimicri
antigen
possibl
vi
rusinduc
antigen
mbp
observ
hlarestrict
prolifer
myelin
viral
antigen
tcell
line
consist
dual
specif
crossreact
cell
mbp
viru
sinc
less
cultur
well
contain
antigenreact
cell
poisson
distribut
suggest
antigenspecif
tcell
line
deriv
individu
microcultur
well
like
repres
monoclon
respons
myelin
viral
antigen
report
other
detect
uniqu
vp
molecul
tcr
tcell
line
recogn
mbp
viral
antigen
also
consist
clonal
although
need
confirm
sequenc
variabl
region
tcr
sever
crossreact
tcell
line
possibl
observ
crossreact
pattern
result
select
independ
virusand
mbpreactiv
cell
present
overal
popul
either
viru
mbp
antigen
formal
exclud
would
also
interest
observ
sinc
preferenti
occurr
ms
patient
consist
possibl
patholog
relev
often
lower
stimul
indic
observ
heterolog
antigen
compar
homolog
select
antigen
see
fig
data
frequent
mbp
reactiv
ms
patientderiv
cell
select
vitro
viru
exposur
consist
possibl
activ
least
portion
mbpreactiv
cell
observ
peripheri
cn
ms
patient
could
trigger
patient
otherwis
innocu
respiratori
coronaviru
infect
differ
frequenc
tcell
crossreact
patient
relaps
form
diseas
compar
progress
diseas
correl
sever
neurolog
dysfunct
suggest
develop
crossreact
direct
consequ
cn
tissu
injuri
interest
tcell
line
ms
patient
show
mbp
reactiv
select
viru
five
patient
bear
che
haplotyp
presum
associ
genet
suscept
diseas
although
ms
patient
control
subject
also
show
virusmyelin
tcell
crossreact
suggest
crossreact
direct
consequ
presenc
hla
haplotyp
also
noteworthi
reciproc
crossreact
coronavirusmyelin
tcell
crossreact
pattern
observ
much
increas
frequenc
ms
patient
compar
control
subject
specif
one
two
human
coronaviru
serotyp
consist
molecular
mimicri
hypothesi
ms
pathogenesi
find
crossreact
occasion
found
control
donor
rais
issu
prevent
mani
individu
autoreact
cell
develop
autoimmun
diseas
although
ident
crossreact
epitop
remain
determin
redort
number
tcell
clone
studi
difficulti
predict
relev
viral
epitop
inde
identif
biolog
relev
crossreact
epitop
human
coronaviru
mbp
may
part
requir
use
purifi
protein
peptid
studi
progress
moreov
import
look
presenc
virusmyelin
crossreact
cell
within
cn
ms
patient
current
find
regard
tcell
crossreact
human
coronaviru
myelin
antigen
mbp
ms
patient
could
extend
numer
pathogen
endogen
cn
antigen
plp
myelinassoci
glycoprotein
myelin
oligodendrocyt
glycoprotein
cyclicnucleotid
phosphodiesteras
abcrystallin
xi
may
account
lack
coronavirusmbp
crossreact
pattern
ms
patient
virusinduc
cellmedi
autoimmun
molecular
mimicri
provid
unifi
hypothesi
could
explain
suspect
genet
involv
immun
respons
gene
difficulti
associ
one
specif
pathogen
ms
also
consist
report
associ
viral
infect
includ
upper
respiratori
tract
exacerb
ms
well
benefici
effect
ms
patient
interferon
beta
among
mani
action
antivir
properti
author
grate
manon
blair
francin
lamhert
expert
technic
assist
elys
b
invalu
k
tanc
collect
experiment
sampl
donor
distantli
relat
virus
may
requir
strike
structur
homolog
appar
unrel
peptid
stimul
lymphocyt
albeit
differ
degre
moreov
four
nativ
mbp
residu
shown
mbpreactiv
cell
studi
recent
culmin
dr
pierr
duquett
notredam
montrtal
eleg
identif
viral
peptid
could
activ
mbpreactiv
tcell
clone
gener
ms
patient
crossreact
sequenc
predict
experiment
determin
structur
motif
requir
bind
peptid
homolog
immunodomin
domain
mbp
molecul
associ
genet
suscept
develop
ms
peptid
could
activ
tcell
clone
specif
irnmunodomin
epitop
mbp
divers
pathogen
associ
ms
herp
simplex
viru
epsteinbarr
viru
adenoviru
type
influenza
viru
type
reoviru
type
well
pseudomonu
uemginosu
interestingli
peptid
human
coronaviru
predict
bear
necessari
structur
requir
although
could
activat
tcell
clone
studi
may
reflect
experiment
bia
toward
immunodomin
epitop
mbp
limit
help
select
ms
patient
dr
rafickpierr
institur
de
recherch
cliniqu
de
gracious
provid
use
studi
allow
us
share
expertis
molecular
character
tcell
receptor
marcel
desrosi
cytofluorometti
francin
